These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 16499139

  • 1. New strategies for management of oral mucositis in cancer patients.
    Peterson DE.
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [Abstract] [Full Text] [Related]

  • 2. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM, Lenz KL.
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and management of oral mucositis.
    Silverman S.
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):13-21. PubMed ID: 17366929
    [Abstract] [Full Text] [Related]

  • 4. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
    Radtke ML, Kolesar JM.
    J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
    [Abstract] [Full Text] [Related]

  • 5. Updated clinical practice guidelines for the prevention and treatment of mucositis.
    Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology.
    Cancer; 2007 Mar 01; 109(5):820-31. PubMed ID: 17236223
    [Abstract] [Full Text] [Related]

  • 6. Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.
    Prescrire Int; 2007 Aug 01; 16(90):135-8. PubMed ID: 17724832
    [Abstract] [Full Text] [Related]

  • 7. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
    Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST, Mucositis Study Section of the Multinational Association for Supportive Care in Cancer, International Society for Oral Oncology.
    Cancer; 2004 May 01; 100(9 Suppl):2026-46. PubMed ID: 15108223
    [Abstract] [Full Text] [Related]

  • 8. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A, von Hoff D, Schuchter LM.
    J Clin Oncol; 2009 Jan 01; 27(1):127-45. PubMed ID: 19018081
    [Abstract] [Full Text] [Related]

  • 9. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C.
    N Engl J Med; 2004 Dec 16; 351(25):2590-8. PubMed ID: 15602019
    [Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F, Bez C, Carrassi A.
    Minerva Stomatol; 2002 May 16; 51(5):173-86. PubMed ID: 12070468
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W.
    J Clin Oncol; 2008 May 20; 26(15):2489-96. PubMed ID: 18487568
    [Abstract] [Full Text] [Related]

  • 12. Keratinocyte growth factor.
    Athar U, Gentile TC.
    Expert Opin Biol Ther; 2009 Jun 20; 9(6):779-87. PubMed ID: 19456212
    [Abstract] [Full Text] [Related]

  • 13. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C, Epstein J, Sonis S.
    Head Neck; 2003 Dec 20; 25(12):1057-70. PubMed ID: 14648865
    [Abstract] [Full Text] [Related]

  • 14. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
    Tejwani A, Wu S, Jia Y, Agulnik M, Millender L, Lacouture ME.
    Cancer; 2009 Mar 15; 115(6):1286-99. PubMed ID: 19170238
    [Abstract] [Full Text] [Related]

  • 15. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ, Emmanouilides C, Bensinger WI, Gentile T, Blazar B, Shea TC, Lu J, Isitt J, Cesano A, Spielberger R.
    J Clin Oncol; 2006 Nov 20; 24(33):5186-93. PubMed ID: 16391299
    [Abstract] [Full Text] [Related]

  • 16. Palifermin (Kepivance) for myelotoxic-therapy-related mucositis.
    Med Lett Drugs Ther; 2005 Apr 25; 47(1207):36. PubMed ID: 15843784
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
    Beaven AW, Shea TC.
    Drugs Today (Barc); 2007 Jul 25; 43(7):461-73. PubMed ID: 17728847
    [Abstract] [Full Text] [Related]

  • 18. Palifermin for patients with haematological malignancies: shifting nursing practice from symptom relief to prevention of oral mucositis.
    Fliedner M, Baguet B, Blankart J, Davies M, Henriques E, Leather A, Mazur E, Mihály K, Peeters L, Radványiné A, Sedlackova B.
    Eur J Oncol Nurs; 2007 Jul 25; 11 Suppl 1():S19-26. PubMed ID: 17540295
    [Abstract] [Full Text] [Related]

  • 19. Oral mucositis.
    Scully C, Sonis S, Diz PD.
    Oral Dis; 2006 May 25; 12(3):229-41. PubMed ID: 16700732
    [Abstract] [Full Text] [Related]

  • 20. Oral mucositis in cancer therapy.
    Sonis ST.
    J Support Oncol; 2004 May 25; 2(6 Suppl 3):3-8. PubMed ID: 15605918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.